4 Healthcare Stock Stories for Thursday Investment Wellness

Biogen IDEC (NASDAQ:BIIB): Closing price $216.00

Biogen posted first-quarter earnings per share of $1.96, which was well above the Zacks Consensus Estimate of $1.57 and a 41 percent increase from the year-ago quarter. First quarter 2013 revenues rose by 10 percent to $1.415 billion, above the Zacks Consensus Estimate of $1.387 billion, with gains driven by Avonex and Tysabri. What is more, earnings were raised by roughly 17 cents thanks to a lower tax rate; if one-time items are counted, first quarter 2013 earnings increased by 43 percent to $1.79 per share.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

BIIB

Baxter International (NYSE:BAX): Closing price $69.09

Baxter announced that it will present at the Bank of America Merrill Lynch 2013 Health Care Conference on May 14th at 5:40 p.m. Central Time. Those interested may access the presentation from the Baxter corporate website at www.baxter.com, and it will be available for replay through June 13th. The firm develops, makes and markets products which save and sustain the lives of people living with hemophilia, kidney disease, immune disorders, infectious diseases, trauma, and other chronic and acute medical conditions.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

BAX

Cardinal Health (NYSE:CAH): Closing price $44.22

Cardinal has signed new agreements through which to link pharmaceuticals to a network of CVS Caremark Corporation’s (NYSE:CVS) retail pharmacies and distribution centers through mid-2016. The stores and distribution centers serviced under the new contract are basically the same as those serviced in the previous arrangement.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

CAH

Eli Lilly and Company (NYSE:LLY): Closing price $56.43

Lilly has been named to the DiversityInc ”Top 50 Companies for Diversity” list for the third straight year. The list is known as a top assessment of diversity management worldwide. To appear on the list, participating firms must have over 1,000 employees and show strength in key diversity areas, including human capital, CEO commitment, corporate and organizational communications, and supplier diversity, while also exhibiting year-to-year progress in diversity initiatives. This year, 893 companies participated, compared to 587 in 2012.

NASDAQ:BIIB, NYSE:BAX, NYSE:CAH, NYSECVS, NYSE:LLY

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

LLY

Investing Insights: Is Vivus Undervalued?

 

More from The Cheat Sheet